New test may help tailor treatment for early breast cancer
Knowledge-focused
Recruiting now
This study is observing how a genetic test called DCISionRT influences treatment decisions for people with ductal carcinoma in situ (DCIS), a very early form of breast cancer. The test predicts the risk of the cancer returning over 10 years and whether radiation therapy would be …
Sponsor: PreludeDx • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC